Role of OATP transporters in the disposition of drugs

被引:237
作者
Niemi, Mikko [1 ]
机构
[1] Univ Helsinki, Cent Hosp, Dept Clin Pharmacol, FIN-00029 Helsinki, Finland
关键词
OATP; OATP1B1; organic anion transporting polypeptide; pharmacogenetics; pharmacokinetics; SLCO; SLCO1B I; SNP; ORGANIC ANION TRANSPORTER; SINGLE NUCLEOTIDE POLYMORPHISMS; MESSENGER-RNA EXPRESSION; MEDIATED HEPATIC-UPTAKE; PLASMA-CONCENTRATIONS; FUNCTIONAL-CHARACTERIZATION; TRANSPLANT RECIPIENTS; GRAPEFRUIT JUICE; C SLC21A6; SLCO1B1; POLYMORPHISM;
D O I
10.2217/14622416.8.7.787
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
During recent years, it has become increasingly recognized that drug transporters play important roles in drug absorption and disposition. Organic anion transporting polypeptides (OATPs) are membrane transporters critically involved in the cellular uptake of drugs in tissues important for pharmacokinetics, such as the intestine, liver and kidneys. Recent advances in the pharmacogenomics of OATP1B1 have revealed that OATP transporters can play important roles in explaining interindividual variability in drug pharmacokinetics, and thus contribute to interindividual as well as interethnic variability in drug response. This article will provide an up-to-date review of human OATPs and their substrates, and a current compilation of their DNA sequence variations.
引用
收藏
页码:787 / 802
页数:16
相关论文
共 121 条
[1]   LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers [J].
Abe, T ;
Unno, M ;
Onogawa, T ;
Tokui, T ;
Kondo, TN ;
Nakagomi, R ;
Adachi, H ;
Fujiwara, K ;
Okabe, M ;
Suzuki, T ;
Nunoki, K ;
Sato, E ;
Kakyo, M ;
Nishio, T ;
Sugita, J ;
Asano, N ;
Tanemoto, M ;
Seki, M ;
Date, F ;
Ono, K ;
Kondo, Y ;
Shiiba, K ;
Suzuki, M ;
Ohtani, H ;
Shimosegawa, T ;
Iinuma, K ;
Nagura, H ;
Ito, S ;
Matsuno, S .
GASTROENTEROLOGY, 2001, 120 (07) :1689-1699
[2]   Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1 [J].
Abe, T ;
Kakyo, M ;
Tokui, T ;
Nakagomi, R ;
Nishio, T ;
Nakai, D ;
Nomura, H ;
Unno, M ;
Suzuki, M ;
Naitoh, T ;
Matsuno, S ;
Yawo, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (24) :17159-17163
[3]   Molecular characterization of human and rat organic anion transporter OATP-D [J].
Adachi, H ;
Suzuki, T ;
Abe, M ;
Asano, N ;
Mizutamari, H ;
Tanemoto, M ;
Nishio, T ;
Onogawa, T ;
Toyohara, T ;
Kasai, S ;
Satoh, F ;
Suzuki, M ;
Tokui, T ;
Unno, M ;
Shimosegawa, T ;
Matsuno, S ;
Ito, S ;
Abe, T .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2003, 285 (06) :F1188-F1197
[4]   PLASMA-CONCENTRATION PROFILES OF SIMVASTATIN 3-HYDROXY-3-METHYL-GLUTARYL-COENZYME-A REDUCTASE INHIBITORY ACTIVITY IN KIDNEY-TRANSPLANT RECIPIENTS WITH AND WITHOUT CYCLOSPORINE [J].
ARNADOTTIR, M ;
ERIKSSON, LO ;
THYSELL, H ;
KARKAS, JD .
NEPHRON, 1993, 65 (03) :410-413
[5]   Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients [J].
Åsberg, A ;
Hartmann, A ;
Fjeldså, E ;
Bergan, S ;
Holdaas, H .
AMERICAN JOURNAL OF TRANSPLANTATION, 2001, 1 (04) :382-386
[6]   Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites [J].
Backman, JT ;
Lulurila, H ;
Neuvonen, M ;
Neuvonen, PJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 78 (02) :154-167
[7]   Gemfibrozil greatly increases plasma concentrations of cerivastatin [J].
Backman, JT ;
Kyrklund, C ;
Neuvonen, M ;
Neuvonen, PJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 72 (06) :685-691
[8]   Plasma concentrations of active simvastatin acid are increased by gemfibrozil [J].
Backman, JT ;
Kyrklund, C ;
Kivistö, KT ;
Wang, JS ;
Neuvonen, PJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (02) :122-129
[9]   Naringin is a major and selective clinical inhibitor of organic anion-transporting polypeptide 1A2 (OATP1A2) in grapefruit juice [J].
Bailey, D. G. ;
Dresser, G. K. ;
Leake, B. F. ;
Kim, R. B. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (04) :495-502
[10]   Renal hemodynamics and pharmacokinetics of bosentan with and without cyclosporine A [J].
Binet, I ;
Wallnöfer, A ;
Weber, C ;
Jones, R ;
Thiel, G .
KIDNEY INTERNATIONAL, 2000, 57 (01) :224-231